Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manlio Ferrarini

Showing results (21-30 of 123) with videos related to

Pageof 13
Sort By:
Leukemia Research|June 17, 2008
Increased serum BAFF (B-cell activating factor of the TNF family) level is a peculiar feature associated with familial chronic lymphocytic leukemiaStefano Molica, Giovanna Digiesi, Francesca Mauro, et al.
Journal of Clinical Pathology|August 19, 2006
B cell chronic lymphocytic leukaemia/small lymphocytic lymphoma: role of ZAP70 determination on bone marrow biopsy specimensElena Sabattini, Rocio Orduz, Cristina Campidelli, et al.
Hematology. American Society of Hematology. Education Program|November 25, 2003
Biology and treatment of chronic lymphocytic leukemiaMichael J Keating, Nicholas Chiorazzi, Bradley Messmer, et al.
Annals of the New York Academy of Sciences|May 3, 2003
The human marginal zone B cellMariella Dono, Simona Zupo, Monica Colombo, et al.
Blood|October 17, 2007
The opposite effects of IL-15 and IL-21 on CLL B cells correlate with differential activation of the JAK/STAT and ERK1/2 pathwaysDaniela de Totero, Raffaella Meazza, Matteo Capaia, et al.
Leukemia Research|August 21, 2010
More on the determination of Ki-67 as a novel potential prognostic marker in B-cell chronic lymphocytic leukemiaFortunato Morabito, Giovanna Cutrona, Massimo Gentile, et al.
Cancer Research|October 16, 2003
Inhibition of the translocated c-myc in Burkitt's lymphoma by a PNA complementary to the E mu enhancerGiovanna Cutrona, Elisabetta M Carpaneto, Anna Ponzanelli, et al.
European Journal of Haematology|June 16, 2010
Baff serum level predicts time to first treatment in early chronic lymphocytic leukemiaStefano Molica, Giovanna Digiesi, Caterina Battaglia, et al.
Leukemia Research|March 19, 2013
The utility of two prognostic models for predicting time to first treatment in early chronic lymphocytic leukemia patients: results of a comparative analysisStefano Molica, Diana Giannarelli, Massimo Gentile, et al.
Oligonucleotides|July 2, 2005
Therapeutically promising PNA complementary to a regulatory sequence for c-myc: pharmacokinetics in an animal model of human Burkitt's lymphomaLidia C Boffa, Giovanna Cutrona, Michele Cilli, et al.
Pageof 13

Showing results (21-30 of 123) with videos related to

Sort By:
Pageof 13
Leukemia Research|June 17, 2008
Increased serum BAFF (B-cell activating factor of the TNF family) level is a peculiar feature associated with familial chronic lymphocytic leukemiaStefano Molica, Giovanna Digiesi, Francesca Mauro, et al.
Journal of Clinical Pathology|August 19, 2006
B cell chronic lymphocytic leukaemia/small lymphocytic lymphoma: role of ZAP70 determination on bone marrow biopsy specimensElena Sabattini, Rocio Orduz, Cristina Campidelli, et al.
Hematology. American Society of Hematology. Education Program|November 25, 2003
Biology and treatment of chronic lymphocytic leukemiaMichael J Keating, Nicholas Chiorazzi, Bradley Messmer, et al.
Annals of the New York Academy of Sciences|May 3, 2003
The human marginal zone B cellMariella Dono, Simona Zupo, Monica Colombo, et al.
Blood|October 17, 2007
The opposite effects of IL-15 and IL-21 on CLL B cells correlate with differential activation of the JAK/STAT and ERK1/2 pathwaysDaniela de Totero, Raffaella Meazza, Matteo Capaia, et al.
Leukemia Research|August 21, 2010
More on the determination of Ki-67 as a novel potential prognostic marker in B-cell chronic lymphocytic leukemiaFortunato Morabito, Giovanna Cutrona, Massimo Gentile, et al.
Cancer Research|October 16, 2003
Inhibition of the translocated c-myc in Burkitt's lymphoma by a PNA complementary to the E mu enhancerGiovanna Cutrona, Elisabetta M Carpaneto, Anna Ponzanelli, et al.
European Journal of Haematology|June 16, 2010
Baff serum level predicts time to first treatment in early chronic lymphocytic leukemiaStefano Molica, Giovanna Digiesi, Caterina Battaglia, et al.
Leukemia Research|March 19, 2013
The utility of two prognostic models for predicting time to first treatment in early chronic lymphocytic leukemia patients: results of a comparative analysisStefano Molica, Diana Giannarelli, Massimo Gentile, et al.
Oligonucleotides|July 2, 2005
Therapeutically promising PNA complementary to a regulatory sequence for c-myc: pharmacokinetics in an animal model of human Burkitt's lymphomaLidia C Boffa, Giovanna Cutrona, Michele Cilli, et al.
Pageof 13